Clinical Trials Browser

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT06382948 2026-04-03

ADELA

Phase 3 Recruiting

240 enrolled

Breast

Advanced Breast Cancer

NCT06492616 2026-03-27

ELEGANT

Phase 3 Recruiting

4,220 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT06923527 2026-03-27

Circulating Tumor DNA

Phase 2 Recruiting

50 enrolled

Breast

ER+ Breast Cancer

NCT05573126 2026-03-20

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

Phase 1/2 Recruiting

95 enrolled

Breast

Breast Neoplasms

NCT07209449 2026-03-18

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Phase 2 Recruiting

75 enrolled

Gynecologic

Recurrence, Endometrial Neoplasms

NCT06075953 2026-03-16

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Phase 2 Recruiting

400 enrolled

Breast

Carcinoma, Intraductal, Noninfiltrating

Clinical Trials

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

ERADICATE

ELECTRA

ADELA

ELEGANT

Circulating Tumor DNA

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment